| Trial ID: | L1596 |
| Source ID: | NCT06766786
|
| Associated Drug: |
Magnesium Sulfate High Dose
|
| Title: |
Magnesium Supplementation in Simultaneous Pancreas-Kidney Transplantation
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Renal Failure Chronic Requiring Dialysis|Diabetes Mellitus, with Complications|Glomerulosclerosis|Pancreatic Insufficiency (Exocrine and Endocrine)|Transplantation, Kidney|Pancreas Transplantation
|
| Interventions: |
DRUG: Magnesium Sulfate high dose
|
| Outcome Measures: |
Primary: Serum magnesium levels., Serum magnesium levels after surgery at 12 and 48 hours., 48 hours|Perioperative cardiovascular incidents., Incidence rate of intraoperative and postoperative dysrhythmia events for each patient., 48 hours | Secondary: Postoperative neurological incidents., Incidence rate of postoperative confusion, muscle spasms, or weakness in each patient., 48 hours
|
| Sponsor/Collaborators: |
Sponsor: Dr Olu Bamgbade, MD, FRCPC | Collaborators: Central Manchester University Hospitals NHS Foundation Trust (co-sponsor, UK)
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
40
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2008-01-02
|
| Completion Date: |
2020-02-20
|
| Results First Posted: |
|
| Last Update Posted: |
2025-01-09
|
| Locations: |
Central Manchester University Hospital, Manchester, M13 9WU, United Kingdom
|
| URL: |
https://clinicaltrials.gov/show/NCT06766786
|
